Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 137 of 174 found articles
 
 
  PND2 SAFETY AND IMMUNOGENICITY OF REBIF® NEW FORMULATION (RNF) A NEW SUBCUTANEOUS FORMULATION OF INTERFERON BETA-1A 44 MCG THREE TIMES WEEKLY: 1-YEAR RESULTS OF A PHASE IIIB STUDY IN PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS
 
 
Title: PND2 SAFETY AND IMMUNOGENICITY OF REBIF® NEW FORMULATION (RNF) A NEW SUBCUTANEOUS FORMULATION OF INTERFERON BETA-1A 44 MCG THREE TIMES WEEKLY: 1-YEAR RESULTS OF A PHASE IIIB STUDY IN PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS
Author: Simsarian, J
AL-Sabbagh, A
Bennett, R
Stubinski, B
Pardo, G
Appeared in: Value in health
Paging: Volume 10 (2007) nr. 3 pages 1 p.
Year: 2007
Contents:
Publisher: International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 137 of 174 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands